| Old Articles: <Older 7781-7790 Newer> |
|---|
 |
Pharmaceutical Executive
August 1, 2011
William Looney |
Paying for Health -- The Right Way What Big Pharma fails to see is how engagement in health policy is the biggest of reputation builders   |
Pharmaceutical Executive
August 1, 2011
Bill Drummy |
The Slow Dance Toward Obsolescence Does Big Pharma have the emotional connection and intellectual commitment to move with the pace of change? |
Pharmaceutical Executive
August 1, 2011
Ben Comer |
An IOU to Big Pharma Regarding EHR It's a work in progress among electronic health records providers to offer a clear bridge between pharma and physicians. |
Pharmaceutical Executive
August 1, 2011
Ted Prusik |
Cure for the Common Cold Chain Break An increasing number of pharmaceutical products prescribed in the US -- including insulin, vaccines, biologics, chemotherapeutic agents, blood products, and many antibiotics -- are temperature-sensitive. |
Pharmaceutical Executive
August 1, 2011
Ben Comer |
Is the 'Emerging Market' a Dated Concept? When it comes to the emerging markets, executing a few key elements of success are more important than ever. |
Pharmaceutical Executive
August 1, 2011
Joe Dysart |
Giving Press Releases New Legs Social media now gives companies a plethora of creative ways to digitally spread recent company news and keep customers informed |
Pharmaceutical Executive
August 1, 2011 |
Europe in HTA Gridlock Health technology assessments are gridlocked by diverse national requirements, a lack of alignment on processes, and even on the value of their outcomes. |
Pharmaceutical Executive
August 1, 2011
Looney & Comer |
Mind the Gap! No one doubts the importance of health expenditures ? but then, euros, like dollars, don't grow on trees. What industry has not anticipated is a looming deficit and debt crisis of governments in the key mature markets. |
Pharmaceutical Executive
August 1, 2011
Jill Wechsler |
The Supremes Shape Pharma A number of important decisions from the Supreme Court will affect drug marketing, research, and regulation |
Pharmaceutical Executive
August 1, 2011
Peter Houston |
Google+ and Pharma Is Google+ the social media platform that pharma has been waiting for? |
| <Older 7781-7790 Newer> Return to current articles. |
